| Full text | |
| Author(s): Show less - |
Baptista, Abrahao Fontes
[1, 2, 3, 4]
;
Baltar, Adriana
[2, 5]
;
Okano, Alexandre Hideki
[1, 6, 2, 3]
;
Moreira, Alexandre
[7]
;
Campos, Ana Carolina Pinheiro
[8]
;
Fernandes, Ana Mercia
[9]
;
Brunoni, Andre Russowsky
[10, 11]
;
Badran, Bashar W.
[12]
;
Tanaka, Clarice
[2, 13]
;
de Andrade, Daniel Ciampi
[2, 9]
;
da Silva Machado, Daniel Gomes
[14]
;
Morya, Edgard
[15]
;
Trujillo, Eduardo
[1, 2]
;
Swami, Jaiti K.
[16]
;
Camprodon, Joan A.
[17, 18]
;
Monte-Silva, Katia
[2, 19]
;
Sa, Katia Nunes
[20, 2, 21]
;
Nunes, Isadora
;
Goulardins, Juliana Barbosa
[7, 2, 4, 22]
;
Bikson, Marom
[16]
;
Sudbrack-Oliveira, Pedro
[23]
;
de Carvalho, Priscila
[13]
;
Duarte-Moreira, Rafael Jardim
[1, 2]
;
Pagano, Rosana Lima
[8]
;
Shinjo, Samuel Katsuyuki
[24]
;
Zana, Yossi
[1]
Total Authors: 26
|
| Affiliation: Show less - | [1] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo - Brazil
[2] NAPeN Network Rede Nucleos Assistencia & Pesquisa, Sao Bernardo Do Campo - Brazil
[3] Univ Estadual Campinas, Brazilian Inst Neurosci & Neurotechnol, Ctr Pesquisa Invest & Difusao, Fundacao Amparo Pesquisa Estado Sao Paulo BRAINN, Campinas - Brazil
[4] Univ Sao Paulo, Lab Med Invest 54 LIM 54, Sao Paulo - Brazil
[5] Specialized Neuromodulat Ctr Neuromod, Recife, PE - Brazil
[6] Univ Estadual Londrina, Grad Program Phys Educ, Londrina, Parana - Brazil
[7] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo - Brazil
[8] Hosp Sirio Libanes, Lab Neurosci, Sao Paulo - Brazil
[9] Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Ctr Dor, LIM62, Sao Paulo - Brazil
[10] Inst Nacl Biomarcadores Neuropsiquiatria, Lab Neurociencias LIM 27, Serv Interdisciplinar Neuromodulacao, Sao Paulo - Brazil
[11] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Psiquiatria, Sao Paulo - Brazil
[12] Med Univ South Carolina, Dept Psychiat, Charleston, SC 29425 - USA
[13] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Cent, Sao Paulo - Brazil
[14] Univ Fed Rio Grande do Norte, Grad Program Collect Hlth, Natal, RN - Brazil
[15] Santos Dumont Inst, Edmond & Lily Safra Int Neurosci Inst, Macaiba - Brazil
[16] CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10031 - USA
[17] Harvard Med Sch, Boston, MA 02115 - USA
[18] Massachusetts Gen Hosp, Lab Neuropsychiat & Neuromodulat, Boston, MA 02114 - USA
[19] Univ Fed Pernambuco, Appl Neurosci Lab, Recife, PE - Brazil
[20] Escola Bahiana Med & Saude Publ, Salvador, BA - Brazil
[21] Pontificia Univ Catolica Minas Gerais, Dept Physiotherapy, Betim - Brazil
[22] Univ Cruzeiro Sul UNICSUL, Sao Paulo - Brazil
[23] Univ Sao Paulo, Fac Med FMUSP, Sao Paulo - Brazil
[24] Univ Sao Paulo, Fac Med FMUSP, Div Rheumatol, Sao Paulo - Brazil
Total Affiliations: 24
|
| Document type: | Review article |
| Source: | FRONTIERS IN NEUROLOGY; v. 11, NOV 25 2020. |
| Web of Science Citations: | 0 |
| Abstract | |
Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be useful in the treatment of the disorders associated with COVID-19. Objective: To describe the rationale and empirical basis of the use of non-invasive neuromodulation in the management of patients with COVID-10 and related disorders. Methods: We summarize COVID-19 pathophysiology with emphasis of direct neuroinvasiveness, neuroimmune response and inflammation, autonomic balance and neurological, musculoskeletal and neuropsychiatric sequela. This supports the development of a framework for advancing applications of non-invasive neuromodulation in the management COVID-19 and related disorders. Results: Non-invasive neuromodulation may manage disorders associated with COVID-19 through four pathways: (1) Direct infection mitigation through the stimulation of regions involved in the regulation of systemic anti-inflammatory responses and/or autonomic responses and prevention of neuroinflammation and recovery of respiration; (2) Amelioration of COVID-19 symptoms of musculoskeletal pain and systemic fatigue; (3) Augmenting cognitive and physical rehabilitation following critical illness; and (4) Treating outbreak-related mental distress including neurological and psychiatric disorders exacerbated by surrounding psychosocial stressors related to COVID-19. The selection of the appropriate techniques will depend on the identified target treatment pathway. Conclusion: COVID-19 infection results in a myriad of acute and chronic symptoms, both directly associated with respiratory distress (e.g., rehabilitation) or of yet-to-be-determined etiology (e.g., fatigue). Non-invasive neuromodulation is a toolbox of techniques that based on targeted pathways and empirical evidence (largely in non-COVID-19 patients) can be investigated in the management of patients with COVID-19. (AU) | |
| FAPESP's process: | 19/10760-9 - Circadian variability of motor cortex excitability in patients with Mesial Temporal Lobe Epilepsy: a Transcranial Magnetic Stimulation (TMS) study |
| Grantee: | Pedro Sudbrack Oliveira |
| Support Opportunities: | Scholarships in Brazil - Doctorate |
| FAPESP's process: | 18/18695-9 - Deep brain stimulation and Parkinsons Disease: neuroinflammation control as therapeutic target |
| Grantee: | Ana Carolina Pinheiro Campos |
| Support Opportunities: | Scholarships in Brazil - Doctorate (Direct) |